ReviewVerocytotoxin-producing Escherichia coli (VTEC)
Section snippets
Introduction and historical perspective
Verocytotoxin (VT)-producing Escherichia coli (VTEC), also known as Shiga toxin-producing E. coli (STEC), are zoonotic agents which cause a potentially fatal human illness whose clinical spectrum includes diarrhoea, haemorrhagic colitis, and the haemolytic uraemic syndrome (HUS). VTEC are of serious public health concern because of their association with large outbreaks and with HUS, which is the leading cause of acute renal failure in children. Although many VTEC serotype have been associated
The infectious agent
Most members of the species E. coli are commensals in the gastrointestinal tracts of animals and humans. However there are pathogenic groups that cause enteric disease in animals and/or humans that include VTEC, enterotoxigenic E. coli, enteroinvasive E. coli, enteropathogenic E. coli serotypes, and enteroaggregative E. coli (Nataro and Kaper, 1998).
Over 380 different VTEC OH serotypes have now been isolated from humans with gastrointestinal disease and many of these serotypes as well as others
Clinical illness and epidemiology in humans
VTEC cause sporadic infection and outbreaks in humans, with the majority of reported outbreaks of VTEC infection associated with VTEC serotype O157:H7, and with sporadic cases occurring more frequently than outbreak cases (Griffin and Tauxe, 1991). The peak age-related frequency of VTEC-associated diarrhoea and HUS is in young children (Griffin and Tauxe, 1991), although the elderly also are at increased risk. The number of outbreak and sporadic cases of VTEC O157 and non-O157 VTEC typically
VTEC in cattle
A growing number of non-O157 VTEC serotypes have been isolated from animals, and many of these serotypes have been associated with human disease (Beutin et al., 1998, World Health Organization, 1999). The majority of VTEC strains implicated in human disease, including E. coli O157:H7, do not appear to be associated with clinical disease in cattle (Mohammed et al., 1985, Naylor et al., 2005a). E. coli O157 is common in cattle; prevalence estimates in North American beef cattle range from 10% to
Rapid screening methods
Several rapid screening methods are now available including the polymerase chain reaction (PCR) (Nataro and Kaper, 1998) to detect VTEC-specific DNA sequences and various immunospecific methods to detect VT antigen in faeces, either directly or after broth-culture enrichment, or in bacterial culture filtrates (Nataro and Kaper, 1998).
Laboratory culture
Laboratory diagnosis of VTEC infection involves the use of a selective and differential medium, such as sorbitol MacConkey agar (March and Ratnam, 1986), to
Therapy in humans
Most patients with uncomplicated VTEC infection recover fully with general supportive measures (Griffin et al., 1988, Karmali, 1989). Tarr et al. (2005) recommend that patients with confirmed VTEC infection and bloody diarrhoea should be initially admitted to hospital to observe for any signs of progression to HUS and also to limit spread of the infection to the community. There are no specific therapies for HUS and patients should, as far as possible, be managed by specialists with experience
Prevention and control
Optimum control of VTEC needs to involve all stages of food production, from farm to fork. Quantitative risk assessments and simulation models are available which describe stages in the farm-to-fork continuum that contribute to an increased risk of foodborne illness and allow potential control measures to be assessed (Cassin et al., 1998, Jordan et al., 1999, Ebel et al., 2004).
Future perspectives
Evaluating the public health impact of interventions at various stages of the farm to fork continuum is complicated by difficulties in traceability of product from farm to consumers, under-reporting of disease, and difficulties in confirming source identification due to the potential time lag between contamination and recognition of a case or outbreak. Currently VTEC infection in animals is not a reportable or ‘named’ disease in agricultural regulations word-wide. This may change in some
Conflict of interest
None.
References (125)
- et al.
Subversion of actin dynamics by EPEC and EHEC
Curr. Opin. Microbiol.
(2006) - et al.
Quantitative risk assessment for Escherichia coli O157:H7 in ground beef hamburgers
Int. J. Food Microbiol.
(1998) - et al.
Serological identification of Escherichia coli O157 infection in haemolytic uraemic syndrome
Lancet
(1991) - et al.
Draft risk assessment of the public health impact of Escherichia coli O157:H7 in ground beef
J. Food Prot.
(2004) - et al.
Factors associated with fecal shedding of verotoxin-producing Escherichia coli O157 on dairy farms
J. Food Prot.
(1999) - et al.
An investigation of factors associated with the prevalence of verocytotoxin-producing Escherichia coli O157 shedding in Scottish beef cattle
Vet. J.
(2007) - et al.
Association of herd management factors with colonization of dairy cattle by Shiga toxin-positive Escherichia coli O157
J. Food Prot.
(1998) - et al.
Prevalence of shiga toxin-producing Escherichia coli in dairy cattle and their products
J. Dairy Sci.
(2005) - et al.
A simulation model for studying the role of pre-slaughter factors on the exposure of beef carcasses to human microbial hazards
Prev. Vet. Med.
(1999) - et al.
Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections
Diagn. Microbiol. Infect. Dis.
(1999)
Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli
Lancet i
Incidence, duration, and prevalence of Escherichia coli O157:H7 fecal shedding by feedlot cattle during the finishing period
J. Food Prot.
Post-harvest interventions to reduce/eliminate pathogens in beef
Meat Sci.
Antibiotic resistance of Escherichia coli O157:H7 and O157:NM isolated from animals, food, and humans
J. Food Prot.
Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain
Res. Microbiol.
Enterohaemorrhagic E. coli in veterinary medicine
Int. J. Med. Microbiol.
Antimicrobial efficacy of UV radiation on Escherichia coli O157:H7 (EDL 933) in fruit juices of different absorptivities
J. Food Prot.
Effect of a vaccine product containing type III secreted proteins on the probability of Escherichia coli O157:H7 fecal shedding and mucosal colonization in feedlot cattle
J. Food Prot.
Efficacy of dose regimen and observation of herd immunity from a vaccine against Escherichia coli O157:H7 for feedlot cattle
J. Food Prot.
Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins
Vaccine
Consumer food handling in the home: a review of food safety studies
J. Food Prot.
Prevalence, risk factors, O-serogroups, and virulence profiles of Shiga toxin-producing bacteria from cattle production environments
J. Food Prot.
Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2–5-year-old children
J. Infect. Dis.
Phage-typing scheme for Escherichia coli O157:H7
J. Infect. Dis.
Fecal carriage of Escherichia coli O157:H7 and carcass contamination in cattle at slaughter in northern Italy
Int. Microbiol.
Emerging foodborne diseases
Emerg. Infect. Dis.
Preliminary foodnet data on the incidence of infection with pathogens transmitted commonly through food—10 states
Morb. Mort. Wkly Rep.
Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum
Curr. Microbiol.
Influence of apple cultivars on inactivation of different strains of Escherichia coli O157:H7 in apple cider by UV irradiation
Appl. Environ. Microbiol.
Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany
Emerg. Infect. Dis.
Localization of intravenously administered verocytotoxins (shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits
Infect. Immun.
Verotoxin-producing Escherichia coli in Spain: prevalence, serotypes, and virulence genes of O157:H7 and non-O157 VTEC in ruminants, raw beef products, and humans
Exp. Biol. Med. (Maywood.)
The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7
Nucleic Acids Res.
What are we doing about Escherichia coli O157:H7 in cattle?
J. Anim. Sci.
Effectiveness of public health interventions in food safety: a systematic review
Can. J. Public Health
A severe outbreak of Escherichia coli O157:H7-associated haemorrhagic colitis in a nursing home
N. Engl. J. Med.
A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome
Clin. Nephrol.
Comparison of shiga-toxigenic Escherichia coli prevalences among dairy, feedlot, and cow-calf herds in Washington State
Appl. Environ. Microbiol.
Type III secretion systems and disease
Clin. Microbiol. Rev.
Incidence and tracking of Escherichia coli O157:H7 in a major produce production region in California
PLoS. ONE.
Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains
Appl. Environ. Microbiol.
Dissecting virulence: systematic and functional analyses of a pathogenicity island
Proc. Natl. Acad. Sci. U.S.A.
Isolation of Escherichia coli O157:H7 from retail fresh meats and poultry
Appl. Environ. Microbiol.
Prevention and decontamination of Escherichia coli O157:H7 on raw beef carcasses in commercial beef abattoirs
J. Rapid Methods Automation Microbiol.
Correlation of enterohaemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing
Proc. Natl. Acad. Sci. U.S.A.
Intervention to reduce fecal shedding of enterohaemorrhagic Escherichia coli O157:H7 in naturally infected cattle using neomycin sulfate
J. Anim. Sci.
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes; RNA N-glycosidase activity of the toxins
Eur. J. Biochem.
Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7
J. Infect. Dis.
Probiotics in man and animals
J. Appl. Bacteriol.
Cited by (406)
Boundaries That Prevent or May Lead Animals to be Reservoirs of Escherichia coli O104:H4
2023, Journal of Food ProtectionSpatiotemporal dynamics of Escherichia coli presence and magnitude across a national groundwater monitoring network, Republic of Ireland, 2011–2020
2022, Science of the Total Environment